Growth hormone and nonalcoholic fatty liver disease. | Immunometabolism (Cobham);5(3): e00030, 2023 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Growth hormone and nonalcoholic fatty liver disease.

Ma, Ingrid L; Stanley, Takara L.

Affiliation

Ma IL; Metabolism Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA, USA.
Stanley TL; Metabolism Unit, Endocrine Division, Massachusetts General Hospital, Boston, MA, USA.

Immunometabolism (Cobham) ; 5(3): e00030, 2023 Jul.

Article in En | MEDLINE | ID: mdl-37520312

Key words

growth hormone; insulin-like growth factor-1; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; releasing hormone

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Immunometabolism (Cobham) Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Immunometabolism (Cobham) Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom